Citations (3)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Andrew Blauvelt, Kenneth B. Gordon, Patricia Lee, Jerry Bagel, Howard Sofen, Benjamin Lockshin, Ahmed M. Soliman, Ziqian Geng, Tianyu Zhan, Gabriela Alperovich & Linda Stein Gold. (2022) Efficacy, safety, usability, and acceptability of risankizumab 150 mg formulation administered by prefilled syringe or by an autoinjector for moderate to severe plaque psoriasis. Journal of Dermatological Treatment 33:4, pages 2085-2093.
Read now
Read now
Articles from other publishers (2)
Tonia Samela, Giorgia Cordella, Valeria Antinone, Paride Sarandrea, Anna Rita Giampetruzzi & Damiano Abeni. (2022) The use of SCL-k-9 to measure general psychopathology in women and men with skin conditions. Frontiers in Psychology 13.
Crossref
Crossref
Steven R. Feldman, Anders Holmen Moeller & Sandra T. Erntoft Idemyr. (2016) Relative Importance of Mode of Administration in Treatment Preferences among Plaque Psoriasis Patients in the United States. Journal of Health Economics and Outcomes Research 4:2, pages 141-157.
Crossref
Crossref